MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Fan F et al. | Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs. | 2015 | Toxicol. Sci. | pmid:25752796 |
Callahan R et al. | Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review. | 2015 | Contraception | pmid:26363431 |
Agarwal SK and Foster WG | Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back. | 2015 | Biomed Res Int | pmid:26247030 |
DiVasta AD et al. | Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial. | 2015 | Obstet Gynecol | pmid:26181088 |
Noguchi LM et al. | Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. | 2015 | Lancet HIV | pmid:26155597 |
Al Abdulhai SA et al. | Bleeding and thrombosis in a patient with primary antiphospholipid syndrome using norethisterone: a case report. | 2015 | J Med Case Rep | pmid:25895835 |
Lakryc EM et al. | What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women? | 2015 | Clinics (Sao Paulo) | pmid:25789519 |
Stachowiak G et al. | Effect of transdermal hormone therapy on platelet haemostasis in menopausal women. | 2015 | Ann Agric Environ Med | pmid:25780849 |
Morrison CS et al. | Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. | 2015 | PLoS Med. | pmid:25612136 |
Zomerdijk IM et al. | Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study. | 2015 | BJOG | pmid:25316196 |